White Paper: Phenoclustering Parkinson’s Disease to Uncover New Targets and Biomarkers

In this white paper, we at BioSymetrics levered phenoclustering with Contingent AI™ to uncover three patient groups in a Parkinson’s Disease cohort, with each group having different biomarker profiles and disease outcomes. This white paper highlights potential targets for new therapeutics and lays the foundation for precision medicine approaches in PD that we are pursuing with our partners.

To request this white paper, fill out the request form to the right.